Lipitor vs. Repatha

See how Lipitor and Repatha compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Lipitor is a daily statin pill that lowers LDL cholesterol and has decades of safety data, while Repatha is an injectable antibody for people who need deeper LDL reduction or cannot tolerate statins.

  • Repatha typically lowers LDL cholesterol more than Lipitor and is usually added on top of statin therapy rather than used in place of it.

  • Lipitor costs far less than Repatha, which has no generic or biosimilar competition and requires an injection every two to four weeks.

Lipitor vs. Repatha Drug Summary

Lipitor

Lipitor (atorvastatin) is an HMG-CoA reductase inhibitor, or statin, that lowers LDL cholesterol and triglycerides while reducing the risk of heart attack and stroke. It is taken as a once-daily oral tablet and has been prescribed since 1996.

Repatha

Repatha (evolocumab) is a PCSK9 inhibitor, a human monoclonal antibody that lowers LDL cholesterol beyond what statins achieve alone. It is given as a subcutaneous injection every two weeks or once monthly, often alongside a statin like Lipitor.

Lipitor vs. Repatha Side Effects

Lipitor

Most common
nasopharyngitis (8.3%)
arthralgia (6.9%)
diarrhea (6.8%)
pain in extremity (6.0%)

Repatha

Most common
nasopharyngitis (up to 10.5%)
upper respiratory tract infection (up to 9.3%)
influenza (up to 7.5%)
back pain (up to 6.2%)

Lipitor vs. Repatha Dosage

Lipitor

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily At the start
Maximum dose 80 mg once daily If needed
Dose changes 3 increases As tolerated

Repatha

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 140 mg every 2 weeks At the start
Maximum dose 420 mg every 2 weeks If needed
Dose changes 2 increases As tolerated

Lipitor vs. Repatha Indications

Lipitor

Lipitor is approved to lower LDL cholesterol and triglycerides in adults and children over 10 with dyslipidemia. It also reduces the risk of heart attack, stroke, and certain heart procedures in people with multiple cardiovascular risk factors, type 2 diabetes, or familial hypercholesterolemia.

  • Lowering LDL and triglycerides in adults and kids 10+

  • Reducing heart attack and stroke risk with CV risk factors

  • Reducing heart attack and stroke risk in type 2 diabetes

  • Treating heterozygous familial hypercholesterolemia in teens

Repatha

Repatha is approved to reduce the risk of heart attack, stroke, and certain heart procedures in adults with established cardiovascular disease. It is also used to lower LDL cholesterol in people with familial hypercholesterolemia, usually added on to a statin or other LDL-lowering therapy.

  • Reducing heart attack and stroke risk in known heart disease

  • Lowering LDL in heterozygous familial hypercholesterolemia

  • Lowering LDL in homozygous familial hypercholesterolemia

  • Approved for children 10+ with familial hypercholesterolemia

Lipitor vs. Repatha Pros and Cons

Lipitor

Lipitor has decades of safety data, a low cost as a generic, and works well for most people with high cholesterol. Its main risks are muscle-related side effects and drug interactions, and it may not lower LDL enough for people with severe familial hypercholesterolemia.

Pros

  • Oral tablet, no injections needed

  • Decades of real-world safety data since 1996

  • Available generically at low cost

  • Roughly $450 to $530 per month, well below Repatha

Cons

  • Risk of muscle pain and rare rhabdomyolysis at higher doses

  • May require liver enzyme monitoring in some patients

  • Interacts with many other medications, raising myopathy risk

  • Usually produces smaller LDL drops than PCSK9 inhibitors

Repatha

Repatha produces much larger LDL reductions than statins alone and has trial evidence for lowering heart attack and stroke risk. It costs significantly more, requires injections, and currently has no generic or biosimilar alternative.

Pros

  • Produces much larger LDL reductions than statins alone

  • Backed by FOURIER trial showing fewer heart attacks and strokes

  • Only one or two doses per month, no daily pill

  • Option for people who cannot tolerate statins

Cons

  • Requires an injection every two to four weeks

  • Injection site reactions and possible latex sensitivity

  • No biosimilar competition yet, keeping cost high

  • Roughly $580 to $730 per month, more than atorvastatin

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.